Literature DB >> 23828652

Real-time FDG PET/CT-guided bone biopsy in a patient with two primary malignancies.

Aung Zaw Win1, Carina Mari Aparici.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23828652     DOI: 10.1007/s00259-013-2492-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  4 in total

Review 1.  Diagnosis and staging of cancer of the esophagus and esophagogastric junction.

Authors:  Zhigang Li; Thomas W Rice
Journal:  Surg Clin North Am       Date:  2012-10       Impact factor: 2.741

2.  Utility of 18F-FDG PET/CT in diagnosis and management of mucormycosis.

Authors:  Yuejian Liu; Hubing Wu; Fen Huang; Zhiping Fan; Bing Xu
Journal:  Clin Nucl Med       Date:  2013-09       Impact factor: 7.794

3.  Can FDG PET be used to successfully direct preoperative biopsy of soft tissue tumours?

Authors:  S F Hain; M J O'Doherty; J Bingham; C Chinyama; M A Smith
Journal:  Nucl Med Commun       Date:  2003-11       Impact factor: 1.690

4.  The impact of coaxial core biopsy guided by FDG PET/CT in oncological patients.

Authors:  Juliano Julio Cerci; Carlos Cunha Pereira Neto; Cassiano Krauzer; Danielle Giacometti Sakamoto; João Vicente Vitola
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-26       Impact factor: 9.236

  4 in total
  2 in total

1.  Feasibility of a multimodal (18)F-FDG-directed lymph node surgical excisional biopsy approach for appropriate diagnostic tissue sampling in patients with suspected lymphoma.

Authors:  Stephen P Povoski; Nathan C Hall; Douglas A Murrey; Chadwick L Wright; Edward W Martin
Journal:  BMC Cancer       Date:  2015-05-08       Impact factor: 4.430

2.  18F-FDG PET/CT oncologic imaging at extended injection-to-scan acquisition time intervals derived from a single-institution 18F-FDG-directed surgery experience: feasibility and quantification of 18F-FDG accumulation within 18F-FDG-avid lesions and background tissues.

Authors:  Stephen P Povoski; Douglas A Murrey; Sabrina M Smith; Edward W Martin; Nathan C Hall
Journal:  BMC Cancer       Date:  2014-06-19       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.